https://immunityforhealth.be/all-news/member-news-naobios-and-sumagen-successfully-optimize-hiv-vaccine-candidate-for-industrial-production/2025-02-04T10:31:24+00:00https://immunityforhealth.be/all-news/epidemic-zika-virus-strains-from-the-asian-lineage-induce-an-attenuated-fetal-brain-pathogenicity/2025-02-04T10:00:41+00:00https://immunityforhealth.be/all-news/p95-and-latinaba-enter-a-strategic-partnership-to-propel-vaccine-research-in-latin-america/2025-02-04T10:01:21+00:00https://immunityforhealth.be/all-news/researchers-now-know-why-cancers-often-spread-to-the-lungs/2025-02-04T10:02:26+00:00https://immunityforhealth.be/all-news/start-up-stories-eric-halioua-pdcline-pharma/2025-02-04T10:43:00+00:00https://immunityforhealth.be/all-news/idevax-secures-e3m-in-series-a-funding-to-revolutionize-skin-drug-delivery/2025-02-04T10:47:26+00:00https://immunityforhealth.be/all-news/specific-types-of-liver-immune-cells-are-required-to-deal-with-injury/2025-02-04T15:04:33+00:00https://immunityforhealth.be/all-news/transvac-a-pillar-of-vaccine-development-in-europe-for-16-years/2025-02-04T15:03:41+00:00https://immunityforhealth.be/all-news/multi-stakeholder-call-to-action-for-the-future-of-vaccine-post-marketing-monitoring-proceedings-from-the-first-beyond-covid-19-monitoring-excellence-become-conference/2025-02-04T15:11:28+00:00https://immunityforhealth.be/all-news/improving-the-immunogenicity-of-the-pneumococcal-conjugate-vaccine-using-a-synthetic-carbohydrate-fatty-acid-monosulphate-squalane-in-water-adjuvant/2025-02-21T15:01:25+00:00https://immunityforhealth.be/all-news/simabs-is-officially-gmp-certified/2025-02-21T15:24:34+00:00https://immunityforhealth.be/all-news/idevax-announces-ce-marking-for-vax-id-intradermal-drug-delivery-device/2025-04-14T14:46:32+00:00https://immunityforhealth.be/all-news/the-pneumococcal-vaccination-puzzle-one-piece-to-solve-the-healthcare-capacity-crisis-in-an-ageing-population/2025-04-30T11:03:12+00:00https://immunityforhealth.be/all-news/astrivax-therapeutics-initiates-clinical-development-of-avx70371-a-hepatitis-b-immunotherapy-using-launch-it-technology/2025-06-05T07:36:47+00:00https://immunityforhealth.be/all-news/advancing-public-health-hpv-belgium-2030/2025-11-06T15:03:07+00:00https://immunityforhealth.be/all-news/new-member-of-the-board-dieter-vancraeynest/2025-06-18T07:50:42+00:00https://immunityforhealth.be/all-news/first-babies-vaccinated-against-mpox-in-the-democratic-republic-of-congo/2025-07-01T12:14:34+00:00https://immunityforhealth.be/all-news/vaxthera-and-quantoom-biosciences-achieve-breakthrough-in-poultry-vaccination-against-highly-pathogenic-avian-influenza-hpai-using-quantooms-n-force-toolbox-for-sarna/2025-07-02T07:08:28+00:00https://immunityforhealth.be/all-news/t-cells-responses-after-vaccination-a-regulatory-perspective/2025-07-02T10:00:34+00:00https://immunityforhealth.be/all-news/enterotoxigenic-escherichia-coli-heat-labileenterotoxin-induces-cell-death-and-disruptseffector-functions-in-porcine-monocytes/2025-07-15T09:37:47+00:00https://immunityforhealth.be/all-news/press-release-sanofi-to-acquire-vicebio-expanding-respiratory-vaccines-pipeline/2025-07-23T13:39:34+00:00https://immunityforhealth.be/all-news/pierre-van-damme-honorary-title-of-baron/2025-07-23T15:00:41+00:00https://immunityforhealth.be/all-news/fda-approves-shingrix-in-a-prefilled-syringe-presentation/2025-07-25T07:27:03+00:00https://immunityforhealth.be/all-news/innoser-connected-pathology-and-poulpharm-announce-strategic-partnership-to-expand-preclinical-and-histopathology-services/2025-08-20T08:10:48+00:00https://immunityforhealth.be/all-news/challenges-and-opportunities-in-mrna-vaccine-development-against-bacteria/2025-08-22T06:38:22+00:00https://immunityforhealth.be/all-news/flanders-vaccine-marks-10th-anniversary-of-immunity-for-health-with-a-new-identity-and-global-vision/2025-10-15T09:07:48+00:00https://immunityforhealth.be/all-news/first-controlled-human-infection-study-at-vaccinopolis-in-collaboration-with-nivi-research-center-and-support-from-province-of-antwerp/2025-10-23T11:20:44+00:00https://immunityforhealth.be/all-news/vub-professor-damya-laoui-receives-the-2025-gsk-vaccines-prize-for-research-into-cancer-immunotherapy/2025-11-18T08:22:31+00:00https://immunityforhealth.be/all-news/loud-applause-greets-survival-data-at-esmo-2025-that-mark-new-era-for-bladder-cancer-care/2025-11-18T11:03:56+00:00https://immunityforhealth.be/all-news/vub-professor-damya-laoui-receives-the-2025-gsk-vaccines-prize-for-research-into-cancer-immunotherapy-2/2025-11-18T10:33:39+00:00https://immunityforhealth.be/all-news/p95-and-julius-clinical-merge-to-form-global-science-led-cro-delivering-integrated-clinical-development-and-real-world-evidence/2025-11-20T10:42:53+00:00https://immunityforhealth.be/all-news/cepi-calls-for-experts-to-join-its-scientific-advisory-committee/2026-01-12T16:06:43+00:00https://immunityforhealth.be/all-news/genomic-epidemiology-of-sars-cov-2-in-peru-from-2020-to-2024/2026-01-12T16:17:33+00:00https://immunityforhealth.be/all-news/advancing-public-health-a-roadmap-to-the-implementation-of-tools-required-to-eliminate-hpv-related-cancers-and-diseases-in-belgium-by-2030/2026-03-09T19:52:11+00:00https://immunityforhealth.be/all-news/recombinant-zoster-vaccine-is-associated-with-a-reduced-risk-of-dementia/2026-03-09T19:33:21+00:00https://immunityforhealth.be/all-news/durability-of-the-bnt162b2-xbb-1-5-adapted-vaccine-against-jn-1-hospitalisation-in-europe/2026-03-13T09:37:39+00:00https://immunityforhealth.be/all-news/immunopeptidomics-of-cutaneous-leishmaniasis-patients-reveals-the-natural-antigenic-landscape/2026-03-13T09:37:26+00:00https://immunityforhealth.be/all-news/simabs-raises-e5m-series-a-to-scale-continuous-antibody-manufacturing/2026-03-12T15:00:38+00:00https://immunityforhealth.be/all-news/sagitta-biotech-announces-positive-preclinical-results-marking-a-key-milestone-in-platform-development-and-pipeline-advancement/2026-03-19T13:30:49+00:00https://immunityforhealth.be/all-news/naobios-and-sgs-partner-to-manufacture-respiratory-syncytial-virus-rsv-challenge-agent/2026-03-18T11:05:09+00:00https://immunityforhealth.be/all-news/cd4-t-cell-mediated-immunity-protects-from-vsv-sud-lethal-challenge-in-a-mouse-model-of-sudan-virus-infection/2026-04-02T20:10:37+00:00https://immunityforhealth.be/all-news/swiftpharma-and-benno-therapeutics-expand-rd-footprint-with-new-collaborative-site-in-leuven/2026-04-08T13:13:33+00:00https://immunityforhealth.be/all-news/simabs-and-ardent-biopharma-announce-strategic-partnership-to-advance-next-generation-biosimilar-manufacturing/2026-04-08T12:48:15+00:00https://immunityforhealth.be/all-news/shape-matters-inside-molecular-clamp-vaccines/2026-04-24T11:56:45+00:00https://immunityforhealth.be/all-news/hpv-vaccine-reimbursement-extended-up-to-age-30-starting-june-2026/2026-05-05T09:06:53+00:00https://immunityforhealth.be/all-news/epstein-barr-virus-and-multiple-sclerosis-new-research-strengthens-the-link/2026-05-12T20:35:38+00:00https://immunityforhealth.be/all-news/hantavirus-outbreak-on-cruise-ship-hondius-latest-update-and-scientific-context/2026-05-13T09:19:55+00:00https://immunityforhealth.be/all-news/ebola-outbreak-in-the-drc-and-uganda/2026-05-24T10:00:03+00:00